SCHEMBL30748520

SCHEMBL30748520

N#Cc1ccccc1N1CCOCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
HSD17B10 Q99714 2/20 0.58
MAPK1 P28482 1/20 0.57
HTT P42858 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
ATM Q13315 1/20 0.51
LMNA P02545 2/20 0.50
MAPT P10636 2/20 0.50
NSD2 O96028 1/20 0.50
TSHR P16473 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50
CASP6 P55212 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL140064 1.00 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL18315290 0.86 HSD17B10 (0.51) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL10330185 0.86 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL3088832 0.86 DRD4 (0.54) KDM4EALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL946142 0.83 ALDH1A1 (0.49) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL18945536 0.83 HSD17B10 (0.49) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL829177 0.82 AR (0.65) KDM4EALDH1A1MAPK1HTTL3MBTL1
SCHEMBL30406641 0.82 AR (0.59) KDM4EALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL3611154 0.81 AR (0.73) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL9424119 0.81 LMNA (0.62) KDM4EALDH1A1HPGDHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112538072-B Aminopyrimidine EGFR inhibitors 齐鲁制药有限公司 2024-02-06 CN disclosed